Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN3 | Q9UGI6 | 14/20 | 0.57 |
| ▸ | KCNN1 | Q92952 | 2/20 | 0.56 |
| ▸ | KCNN2 | Q9H2S1 | 2/20 | 0.56 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.55 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.39 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.39 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.39 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.39 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.39 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.39 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.39 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7887263 | 0.82 | PDE10A (0.41) | KCNN3KCNN1KCNN2PDE10APRKAB2 | |
| SCHEMBL7879251 | 0.82 | KCNN3 (0.38) | KCNN3KCNN1KCNN2PDE10APRKAB2 | |
| SCHEMBL7874462 | 0.81 | CCNT1 (0.43) | — | |
| SCHEMBL10209999 | 0.78 | PDE10A (0.53) | KCNN3KCNN1KCNN2PDE10A | |
| SCHEMBL39693 | 0.78 | PDE10A (0.50) | KCNN3KCNN1KCNN2PDE10A | |
| SCHEMBL5447969 | 0.77 | KCNN3 (0.66) | KCNN3KCNN1KCNN2PDE10APRKAB2 | |
| SCHEMBL10210928 | 0.77 | PDE10A (0.49) | KCNN3KCNN1KCNN2PDE10A | |
| SCHEMBL47770 | 0.77 | PDE10A (0.49) | KCNN3KCNN1KCNN2PDE10A | |
| SCHEMBL30278 | 0.75 | PDE10A (0.46) | KCNN3KCNN1KCNN2PDE10ACRHR1 | |
| SCHEMBL14158199 | 0.73 | PDE10A (0.61) | KCNN3KCNN1KCNN2PDE10APRKAB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012027234-A1 | FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN | SCHERING CORPORATION (US) | 2012-03-01 | — | — | WO | disclosed |
| WO-2011090935-A1 | PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2011-07-28 | — | — | WO | disclosed |